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Abstract 1 
Background: In the United Kingdom (UK), exercise intensity is prescribed from a fixed 2 
percentage range (% heart rate reserve; %HRR) in cardiac rehabilitation (CR) programmes. 3 
We aimed to determine the accuracy of this approach by comparing it with an objective, 4 
threshold-based approach incorporating the accurate determination of ventilatory 5 
anaerobic threshold (VAT). We also aimed to investigate the role of baseline 6 
cardiorespiratory fitness status, and exercise testing mode dependency (cycle v treadmill 7 
ergometer) on these relationships.  8 
Design/Methods: A maximal cardiopulmonary exercise test was conducted on a cycle 9 
ergometer or a treadmill before and following usual-care circuit training from two separate 10 
CR programmes from a single region in the UK. The heart rate corresponding to VAT was 11 
compared to current heart rate-based exercise prescription guidelines.   12 
Results: We included 112 referred patients (61 years [59-63]; body mass index 29 kg∙m-2 13 
[29-30]; 88% male). There was a significant but relatively weak correlation (r=0.32; P=0.001) 14 
between measured and predicted %HRR, and values were significantly different from each 15 
other (P=0.005). Within this cohort, we found that 55% of patients had their VAT identified 16 
outside of the 40-70% predicted HRR exercise training zone. In the majority of participants 17 
(45%), the VAT occurred at an exercise intensity <40% HRR). Moreover, 57% of patients with 18 
low levels of cardiorespiratory achieved VAT at <40% HRR. Whereas, 30% of patients with 19 
higher fitness achieved their VAT at >70% HRR. VAT was significantly higher on the treadmill 20 
than the cycle ergometer (P<0.001).  21 
Conclusion: In the UK, current guidelines for prescribing exercise intensity are based on a 22 
fixed percentage range. Our findings indicate that this approach may be inaccurate in a large 23 
proportion of patients undertaking CR.  24 
Word Count: 274 words 25 
Key words: cardiac rehabilitation, exercise prescription, cardiorespiratory fitness, 26 
ventilatory anaerobic threshold. 27 
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Introduction 1 
Cardiovascular rehabilitation (CR) is a multi-disciplinary secondary prevention programme 2 
that has been shown to contribute to reduced hospital admissions, and improvements in 3 
patient quality of life, following a cardiac event.(1-4) Historically, a 1% improvement in peak 4 
oxygen uptake (VO2peak) resulting from exercise-based CR, was thought to confer a 2% 5 
reduction in premature mortality.(5) Similarly, every 3.5 ml.kg-1.min-1 increment in VO2peak 6 
has been associated with a 12-13% survival benefit (6, 7) in men referred for exercise 7 
testing. Therefore, it is essential that the prescribed dose of exercise is sufficient to 8 
stimulate improvements in VO2peak following CR. Recent systematic reviews and meta-9 
analyses have shown that increased exercise intensity is an important factor in achieving 10 
superior outcomes in patients with cardiovascular disease.(8, 9)  11 
The prescribed dose of exercise can be influenced by manipulating exercise frequency, 12 
duration, type/mode, and/or intensity [exercise dose].(10) In the United Kingdom (UK), 13 
current long-term exercise training guidelines for patients undertaking CR, recommend 14 
exercise training intensities between 40-70% heart rate reserve (HRR), oxygen uptake 15 
reserve (VO2R), or a Borg rating of perceived exertion (RPE) between 11-14.(11, 12) Both 16 
continuous and interval training at an objective physiological threshold has been shown to have a 17 
beneficial impact by improving VO2peak.(13) Training at or above the ventilatory anaerobic 18 
threshold (VAT),  often referred to as the first ventilatory threshold (VT1), indicates the 19 
point above which, further increments in work rate are increasingly supplemented through 20 
anaerobic metabolism.(14-17) Despite being associated with mild metabolic 21 
perturbations,(16, 17) regular exercise bouts conducted at work rates equivalent to VAT are 22 
well tolerated,(18) and induce physiological adaptation leading to improved 23 
cardiorespiratory fitness (CRF) and other cardiovascular risk factors.(19, 20) However, whilst 24 
 4 
work rates corresponding to VAT may represent a minimum intensity needed to improve 1 
CRF, metabolic gas equipment and calibrated ergometers are often not available in a CR 2 
setting in the UK. Prescribing exercise as a percentage of measured HRR, or most typically 3 
estimated HRR,  is often a more practical and realistic alternative in UK cardiac rehabilitation 4 
settings.(10)  5 
The 40% HRR threshold is cited as the lowest effective exercise intensity for improving CRF 6 
in patients undertaking CR.(10, 12) The individual VAT is widely accepted to occur between 7 
45-65% HRR in healthy and cardiac patients,(8) with lower values reported in patients with a 8 
chronic cardiovascular disease.(10) However, the distribution of VAT values, and its relation 9 
to exercise capacity, is unclear in patients undertaking CR. How commonly VAT occurs 10 
within discrete exercise intensity ranges is also under-reported in patients with coronary 11 
artery disease. Tan et al (21) showed that the mean VAT was equal to 82% of maximal heart 12 
rate (HR), in 19 cardiac patients referred for a cardiopulmonary exercise test (CPET) prior to 13 
CR, (21). However, the mode of exercise testing may also influence when an individual’s VAT 14 
occurs.  15 
In the UK, the mode of exercise testing varies between CR programmes. This means that a 16 
patient’s exercise prescription could be based on a number of different submaximal exercise 17 
tests, including the 6-min walk test, incremental shuttle walk test, step test, or cycle 18 
ergometry. The differing metabolic responses to cycling compared with walking may affect a 19 
patient’s peak oxygen uptake (V̇O2peak), and the occurrence of VAT. This, in turn, may 20 
significantly affect the accuracy of exercise intensity prescription. These issues have not 21 
been addressed sufficiently within UK guidelines for exercise prescription in CR 22 
programmes. This information may help practitioners to optimise a patient's initial exercise 23 
 5 
prescription and maximise the improvements associated with exercise training 1 
programmes. This is especially important when the frequency and duration of CR sessions 2 
are finite. We aimed to determine the accuracy of the standard UK approach for prescribing 3 
exercise in patients undertaking CR by comparing it with objective measures of exercise 4 
prescription, namely V̇O2peak and VAT.  Secondary aims were to determine how exercise 5 
modality (exercise testing with cycle versus treadmill ergometer), and baseline levels of CRF 6 
affected the concordance of VAT and HRR measures. 7 
 8 
Methods 9 
Data was collated from the baseline assessment of two separate cohorts who undertook a 10 
maximal effort CPET to volitional exhaustion prior to commencing a CR programme. The 11 
methods for these studies have previously been reported.(22, 23) Ethical approval was 12 
provided by the Yorkshire and Humber – Sheffield National (12/YH/0072) and Humber 13 
Bridge NHS (12/YH/0278) Research Ethics Committees. Briefly, patients were recruited 14 
following a referral to CR for angina, myocardial infarction (MI), coronary artery bypass graft 15 
(CABG), or percutaneous coronary intervention (PCI). Patients attended a baseline study 16 
assessment, where written informed consent was obtained. CPET was conducted on a cycle 17 
ergometer following a 25W incremental protocol, or on a treadmill following the modified 18 
Bruce protocol,(24) adopting previously outlined test termination and maximal effort 19 
criteria.(15, 25) Breath-by-breath metabolic gas exchange data were collected using an 20 
Innocor (Innovision, Glamsbjerg, Denmark) or Oxycon-Pro metabolic cart (Jaeger, 21 
Hoechburg, Germany), respectively, which were calibrated according to manufacturers’ 22 
instructions and current recommendations.(26) Peak values were averaged over the final 30 23 
 6 
seconds of the CPET. VO2peak was reported in absolute values (L·min-1) and standardised to 1 
each patient's body mass (ml.kg-1.min-1). Individualised VAT was independently determined 2 
by two investigators (using the average of the middle five of every seven breaths plotted in 3 
the V-slope method, and verified using the ventilatory equivalents.(14, 27) Where 4 
investigators reported different VAT values, a third reviewer was consulted and the 5 
threshold value agreed by consensus. The VAT was reported in L∙min-1 and ml.kg-1.min-1 and 6 
expressed as a percentage of directly-determined and predicted VO2peak.(28) The HR at VAT 7 
was then established and reported as a ratio of HRmax and HRR determined from CPET, and 8 
as a ratio of predicted HRmax and HRR with relevant adjustment for the effects of beta-9 
blockade on maximal heart rates as follows [10]): 10 
 11 
((205.8 - (0.685 x age)) – resting heart rate (-30 beats per min if taking beta-blockers) 12 
 13 
To characterise where a patients VAT occurred in relation to established training zones, the 14 
VAT values were categorically assigned to exercise intensity groups of <40%, 40-49%, 50-15 
59%, 60-69%, 70%, and >70% of measured, and predicted HRR. Adjustment for β-blockades 16 
were made where appropriate,(12). We assessed how many patients had a VAT that 17 
occurred within the exercise training intensity ranges recommended by UK CR guidelines, 18 
namely 40-70% HRR, or an RPE between 11-14.(11, 12) Patients were sub-categorised 19 
according to individual CRF levels as low (<5 METs for women, <6 METs for men), moderate 20 
(5<7 METs for women, 6<8 METs for men), and high CRF (≥7 METs for women, ≥ 8 METs for 21 
men), based on exercise capacity (MET) thresholds derived from the international literature 22 
and previously applied to cardiac patients in the UK.(29) These sub-groups were then 23 
 7 
categorised based on the HRR zone that the individualised VAT occurred within. We also 1 
conducted sub-analyses on patients who undertook their CPET either on a treadmill or cycle 2 
ergometer.    3 
  4 
Data analysis 5 
Statistical analysis was conducted using SPSS version 24 (IBM, NY, USA). When data was not 6 
normally distributed, normalisation of the distribution was attempted using log10 7 
transformation. Logarithmically transformed data was analysed in its transformed state and 8 
reported as an arithmetic mean to allow for meaningful interpretation. Normally distributed 9 
and transformed data were analysed using a univariate general linear model with 10 
significance set at arbitrary level (P<0.05), and is presented as mean (95% confidence 11 
intervals), and partial-eta squared ( ) effect sizes, with 0.01, 0.06, and 0.14 denoting 12 
small, moderate, and large effects, respectively (30). For non-normally distributed data, a 13 
Mann-Whitney U test was conducted with median and range reported. Categorical data was 14 
analysed using a Chi-squared test of independence and reported as percentage and 15 
frequency. When ≥1 cell had an expected value <5, the Fisher’s exact test was used.  16 
 17 
Results  18 
Patient Characteristics 19 
One-hundred and twelve (n=112) cardiac patients were included for analysis (61.3 years 20 
[59.4-63.1]; 29.3 kg∙m-2 [28.5-30.1]; 88% male). Forty-two patients (n=42; 37.5%) undertook 21 
their CPET on a cycle ergometer. Patients on a cycle ergometer achieved 79.1% of their 22 
predicted HRmax [74.6-83.6%], an RPE of 18 [17-18], and a peak respiratory exchange ratio 23 
 8 
(RER) of 1.02 [1.00-1.05). Seventy (n=70) patients undertook CPET on a treadmill. Patients 1 
conducting CPET on a treadmill achieved 82.3% [79.7-84.9%] of predicted HRmax), an RPE of 2 
17.8 [17.3-18.3], and a peak RER of 1.09 [1.06-1.11]). 77% and 86% of the patients 3 
undergoing cycle and treadmill testing, respectively, were prescribed beta-blockers. The 4 
majority of patients had a diagnosis of myocardial infarction (MI) with primary (32.5%) or 5 
elective (28.9%) PCI. There was a greater prevalence of active smokers (P=0.017) in those 6 
that conducted a CPET on a cycle ergometer. There were significant between-group 7 
differences for age (P=0.012; =0.054), and resting HR (mean difference 5.8bpm (95% CI 8 
1.0-10.5bpm) P=0.032; Table 1) between the test modality groups. 42 out of 112 patients, 9 
were classified within the lower cardiorespiratory fitness group, 50 in the moderate-fit 10 
group, and 20 in the high-fit group (Table 2). 11 
 12 
 13 
VAT, HRR zones, and CRF categories 14 
Measured HRR (72 ± 15 bpm) derived from maximal CPET demonstrated only a modest 15 
correlation with predicted HRR (77.99 ± 20.42bpm) (using current UK CR guidelines (r=0.32; 16 
P=0.001). However, the directly determined and predicted HRR/peak HR variables were 17 
significantly different from each other (mean difference = 6.74bpm (95% CI 2.99-10.49bpm) 18 
P=0.001). The VAT occurred within 40-70% of directly determined HRR range in 61.6% of 19 
patients. In the remaining 38.4% of patients, 33.9% achieved their VAT at <40% HRR, and in 20 
4.5% of patients, their VAT did not occur until >70% HRR. For predicted HRR, VAT occurred 21 
within 40-70% HRR in 44.6% of patients. Of the remaining 55.4% of patients, 45.4% achieved 22 
VAT at <40% HRR, and 9.8% at >70% HRR (Table 2). 23 
 9 
The VAT occurred between 40-70% of predicted HRR in 21.4% of patients undertaking 1 
cycling exercise. The majority (76.2%) of patients exceeded the VAT at <40% HRR. For 2 
patients undertaking CPET on a treadmill, 58.5% of patients had a VAT that occurred 3 
between 40-70% of predicted HRR, and 27.1% had a VAT that occurred at <40% HRR. 4 
Interestingly, the VAT occurred between 40-70% of predicted HRR in 35.8% of patients that 5 
were categorised as having a low CRF. 57.1% of patients exceeded their VAT at <40% of 6 
their HRR. For higher-fit patients, VAT occurred between 40-70% of predicted HRR in 50% of 7 
patients, at <40% HRR in 20%, and >70% HRR for the remaining 30% of patients (Table 2). 8 
Figure 1 shows the inter-quartile range for VAT as a percentage of predicted HRR, based on 9 
CRF category, and exercise testing modality. The VAT occurred at a higher percentage of 10 
VO2peak in patients with a higher CRF. This observation was also evident when CPET was 11 
conducted on a treadmill for all CRF categories, but most apparently in the moderate and 12 
high-fit groups.  13 
 14 
Directly measured compared with predicted cardiorespiratory fitness variables 15 
Mean VO2peak was not significantly different between exercise modality groups in absolute 16 
units (P=0.644; =0.002), or relative to body mass (P=0.359; =0.008) (Table 3). 17 
However, absolute (P=0.027) and relative (P=0.001) VAT was significantly different across 18 
the different CRF groups. VAT occurred at a higher percentage of predicted (P=0.003; 19 
=0.08) and measured VO2peak (P<0.001; =0.151), and HRR (P<0.001; =0.132) in 20 
patients exercising on the treadmill. Measured HRR (P=0.012; =0.056), and HR at VAT 21 
(P=0.016; =0.052) were significantly higher in the treadmill group. There was a significant 22 
 10 
between-group difference for predicted HRmax adjusted for β-blockade (P=0.003; Table 4). 1 
However, there was no difference in predicted HRR (P=0.863 =<0.001) or VO2peak 2 
between groups (P=0.815, <0.001). Figures 2a and 2b highlight individual case studies 3 
which demonstrate how the predicted HRR method can either over- or under- estimate 4 
individualised exercise prescription versus directly determined HRR and VAT.  5 
 6 
Discussion 7 
This study aimed to determine the accuracy of the standard UK approach for prescribing 8 
exercise in patients undertaking CR. This method of determining target heart rates for 9 
exercise training in cardiac patients relies largely on predictive methods for determining 10 
maximal HR (including patients taking beta-blockade). We sought to compare it with a more 11 
objective measure of exercise prescription, namely the VAT derived from respiratory gas 12 
exchange during a maximal CPET. Our findings indicate that current UK CR exercise 13 
prescription guidelines appear susceptible to substantial inaccuracy with more than half of 14 
our cohort achieving a VAT outside the recommended target range of 40-70% HRR. We 15 
found that 45% of patients had VAT identified at <40% HRR, and in 9% of patients, VAT was 16 
identified at >70% HRR, suggesting that the required exercise intensity spectrum is wider 17 
than the recommended 40-70 HRR%.  18 
When considering baseline cardiorespiratory fitness, the proportion of patients whose VAT 19 
occurred outside the guidelines increased. 57% of low-fit patients achieving VAT at <40% 20 
HRR, and 30% of high-fit patients achieving VAT at >70% HRR, confirming that VAT occurs 21 
later with increasing CRF in cardiac patients.(31) For those who achieved VAT at <40% HRR, 22 
 11 
their exercise prescription may overly exceed VAT and prove too challenging, whilst for 1 
those that achieve VAT >70%HRR, their prescription is unlikely to induce a training stimulus 2 
and prove too easy. We speculate that this may contribute to the 23% attrition rate recently 3 
reported in UK CR,(32) as some patients overly exceed their training stimulus (i.e. low fit 4 
patients), which may be uncomfortable, whilst some do not reach it, thus providing minimal 5 
benefit (i.e. high fit patients), both of which may cause patients to discontinue CR. 6 
Therefore, a one size fits all approach, relying on predictive methods for maximal HR and 7 
estimated HRR to prescribe exercise appears ineffective. Exercise prescription within cardiac 8 
rehabilitation settings needs to be more accurate, patient specific and fine-tuned, ideally 9 
based on ventilatory markers, actual HRR and baseline fitness category determined via 10 
CPET.(33) One option could be to shift from ‘range-based’ to ‘threshold-based’ CR exercise 11 
prescription, with moderate-high intensity exercise, corresponding to work rates between 12 
VAT and critical power, being recommended.(17) Based on the current data, CPET would aid 13 
prescription to ensure that all patients achieved VAT during CR, whilst also ensuring it is not 14 
overly exceeded. This is important given that certain cardiac patients, namely those who 15 
may be more deconditioned, often perform activities of daily living at levels of VO2 that 16 
exceed VAT.(34) Therefore, exercising in steady-state conditions above VAT is vital for these 17 
patients, but may not be possible if it is exceeded. In the late 1970s, limitations in the 18 
relative percent method (i.e %HRR) for prescribing exercise intensity were identified, with a 19 
study by Katch et al showing this method failed to consider individual metabolic 20 
differences,(35) yet it is still a recommended approach today.(8,10) More recent 21 
investigations have proposed a more individualised exercise prescription based on 22 
ventilatory thresholds to personalise individualised training load based on metabolic 23 
responses.(36, 37) Recently, Weatherwax et al reported that in sedentary adults, 12 weeks 24 
 12 
of aerobic exercise training based on an individualised exercise prescription using VAT had a 1 
greater effect on the incidence of training response compared to a standardised approach 2 
using HRR. While the exact mechanisms are still not entirely understood, it is believed that 3 
exercise intensity prescribed with the use of ventilatory thresholds takes into consideration 4 
individual metabolic characteristics which are overlooked when using relative percent 5 
methods.(38) 6 
 7 
The current data also indicate that VAT is mode-dependant for the overall cohort and across 8 
all three CRF categories. Similar to previous suggestions,(17) VAT occurred at around 50% 9 
HRR on the treadmill but is 12-15% lower on the cycle. A similar relation has also been 10 
observed in patients with chronic heart failure.(39) This mode dependency is also evident in 11 
terms of predicted HRR zones, which are adopted in most UK CR centres, with >75% of 12 
patients on a cycle ergometer achieving VAT at <40% HRR, compared with just 27% of 13 
patients exercising on a treadmill. Previous research has identified a VAT mode dependency 14 
in cardiac patients based on VO2 .(40) The current results differ somewhat as they show a 15 
mode dependency for patients who are yet to begin as opposed to those who have finished 16 
CR. Furthermore, in the current study this mode dependency is expressed using HRR, which 17 
is adopted in most CR centres, rather than VO2.  18 
UK CR is provided by the state-funded National Health Service, unlike CR operating in other 19 
international and EU countries,(15) the integration of CPET equipment is not currently 20 
incorporated into most UK centres and may prove to be prohibitive.(41) Another possible 21 
solution could be to increase the upper intensity limit of exercise prescription in line with 22 
international guidelines at 80% HRR, especially for patients in a higher fit category.(10, 42) 23 
 13 
Of the 10 patients whose VAT occurred at >70% HRR, 6 achieved VAT at <80% HRR. This 1 
suggests that increasing the upper range of exercise prescription guidelines could be helpful 2 
to a small cohort of patients, and provide greater scope for training progression in those 3 
that could tolerate it; aligning UK guidelines closer to those seen internationally.(43) This 4 
does not however, address the issue for those who achieved VAT at <40%. A further 5 
alternative to personalise exercise prescription across the whole spectrum would be to 6 
identify the HR range corresponding to an RPE of 11-13, given that VAT has been shown to 7 
occur around this point (44, 45). Submaximal testing is routinely performed in UK CR and 8 
identification and utilisation of the HR between these points during testing could ensure 9 
more patients are exercising at or around the VAT. One caveat to such an option is that RPE 10 
is a subjective tool, meaning that appropriate anchoring of key values would be required for 11 
each patient, and this would need to be applied consistently within and between each CR 12 
centre in the UK.  13 
To be able to confidently prescribe an individualised exercise programme in a safe and 14 
effective manner can be challenging in a cardiac population. The healthcare professional 15 
must be able to account for medication usage, presence of non-CV co-morbidities, and for 16 
example, adverse events during exercise testing. Hansen and colleagues [46] showed 17 
significant inter-clinician variance in prescribing exercise for patients with different CVDs, 18 
highlighting the challenges posed. Further training and education is key, however, digital 19 
resources are available to assist practitioner decision-making processes. For example, the 20 
European Association of Preventive Cardiology recently developed the Exercise Prescription 21 
in Everyday Practice and Rehabilitative Training (EXPERT) tool.[47] The EXPERT tool is an 22 
interactive, digital training and decision support system that assists healthcare professionals 23 
in prescribing clinically eﬀective and medically safe exercise training programmes for CVD 24 
 14 
patients. The adoption of tools such as EXPERT should be more widely encouraged and 1 
facilitated to support decision making processes around exercise prescription in cardiac 2 
populations. The impact of their utility within clinical practice could then be audited to 3 
determine changes in efficacy.    4 
 5 
Limitations 6 
The key limitation is that the two groups are made up of separate patients who varied on 7 
some baseline characteristics. Ideally, all patients would have completed a CPET using both 8 
modalities to reduce any individual effect.  9 
 10 
Conclusion 11 
To our knowledge, this is the first study of its kind to explore VAT in terms of prescribed HRR 12 
zones for cardiac patients to identify the accuracy of current UK CR exercise prescription 13 
guidelines. For a large proportion of patients, the guidelines are inaccurate with many 14 
patients achieving VAT at <40% HRR, meaning their exercise prescription may be overly 15 
challenging. Conversely, 30% of high-fit patients achieved VAT at >70% HRR, meaning their 16 
prescription may be too conservative to provide a stimulus. This under/over-prescription 17 
may lead patients to unnecessarily discontinue their CR (see Figures 2a and 2b). Therefore, 18 
for UK CR, a one size fits all approach is ineffective and a shift from predictive equations and 19 
submaximal exercise tests to gold-standard CPET on entry to CR would be required to 20 
improve exercise prescription. However, this may not be viable for a number of reasons, 21 
meaning that adoption of less conservative guidelines could provide a solution to ensuring 22 
that a larger proportion of patients achieve a training stimulus. Furthermore, although 23 
 15 
VO2peak did not demonstrate a mode dependency, VAT did. This suggests that it may be 1 
necessary to conduct a CPET using both modalities, or tailor exercise prescription based on 2 
the modality used. Future research could confirm this mode dependency for HRR at VAT in 3 
cardiac patients by testing the same group of patients twice, once during each modality.4 
 16 
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Table 1. Clinical characteristics of patients grouped by exercise modality  
Mean (95% CI) † = median and ranges  
 
 
 
Variable Pooled (cycle and treadmill data) Cycle Treadmill P-value 
Partial 
eta-
squared 
Sex 
(male/female) 
100/14 (87.70% male) 40/4 (90.0% male) 60/10 (85.7% male) 0.411  
Age (years) 61.25 (95% CI; 59.35 to 63.14) 63.13 (95% CI; 60.75 to 65.51) 58.25 (95% CI; 55.21 to 61.29) 0.012* 0.054 
BMI (kg/m2)T 29.30 (95% CI; 28.54 to 30.07) 30.1 (95% CI; 28.8 to 31.44) 28.80 (95%CI; 29.74 to 27.90) 0.101 0.024 
Resting SBP 
(mmHg)Tr 
131.55(95% CI; 127.94 to 135.27) 139.57 (95%CI 134.39 to 144.95) 126.74(95% CI; 122.18 to 131.46) 0.001** 0.099 
Resting DBP 
(mmHg)† 
83 (60 to 149) 85.50 (62 to 104) 82 (60 to 149) 0.09  
LVEF (%) 55.77 (95% CI; 54.34 to 57.20) 57.05 (95%CI; 54.35 to 59.75) 54.99 (95%CI; 53.35 to 56.62) 0.167 0.017 
Table 1
Resting HR 
(bpm)† 
60 (42 to 95) 64 (44 to 95) 56 (42 to 91) 0.008**  
  
BMI, Body mass index. kg∙m-2, kilogram per metre squared. SBP, systolic blood pressure. mmHg, millimetres of mercury. DBP, diastolic blood pressure. LVEF, left 
ventricular ejection fraction. HR, Heart Rate. Bpm, beats per minute. 
*P<0.05, **P<0.01, ***P<0.001. †, Variables are reported as median (minimum and maximum) values and analysed using a non-parametric test. 
Tr, transformed using log10 transformation and reported as arithmetic mean for meaningful interpretation. 
 
 
Table 2. The occurrence of VAT in relation to predicted HRR training zones, stratified by exercise 
modality and baseline CRF levels 
 
 
Predicted HRR threshold 
Number of patients (%)  
 Pooled cycle and treadmill Cycle Treadmill  
 <40% predicted HRR 51 (45.4%) 32 (76.2%) 19 (27.1%)  
 40-49% predicted HRR 24 (21.4%) 5 (11.9%) 19(27.1%)  
 50-59% predicted HRR 15 (13.4%) 4 (9.5%) 11 (15.7%)  
 60-69% predicted HRR 11 (9.8%) 0 11(15.7%)  
 >70% predicted HRR 11 (9.8%) 1 (2.4%) 10(14.3%)  
 Total within 40-70% HRR 44.6%         21.4% 58.5%  
      
 
Baseline CRF category 
Low Fit Mod Fit High Fit 
<40% predicted HRR 24 (57.1%) 23 (46%) 4 (20%) 
40-49% predicted HRR 11 (26.2%) 11 (22%) 2 (10%) 
50-59% predicted HRR 2 (4.8%) 8 (16%) 5 (25%) 
60-69% predicted HRR 2(4.8%) 6 (12%) 3 (15%) 
>70% predicted HRR 3 (7.1%) 2(4%) 6 (30%) 
Total within 40-70% HRR 35.8% 50% 50% 
Predicted heart rate reserve using current guidelines, accounting for beta-blockade. Baseline fitness 
category based on Taylor et al. (2016); low fit <5 METs for women and <6 METs for men, mod fit = 5<7 METs 
for women and 6<8 METs for men, high fit ≥7 METs for women, and ≥8 METs for men. VAT, ventilatory 
anaerobic threshold. HRR, heart rate reserve. MET, metabolic equivalent where 1 MET = 3.5ml·kg-1·min-1. 
 
Table 2 - Revised
Table 3. Cardiorespiratory data based on maximal CPET in patients using cycle and treadmill exercise modalities 
 
 
 
 
 
 Pooled Cycle Treadmill P-value Partial eta-
squared 
VO2peak (L·min-1) 2.00 (95% CI; 1.88 
to 2.11) 
2.03 (95% CI; 1.82 
to 2.25) 
1.98 (95% CI; 1.83 to 
2.12) 
0.644 0.002 
VO2peak (ml·kg-1·min-1) Tr 22.12 (95% CI; 19.8 
to 24.7) 
21.43 (95% CI; 18.0 
to 25.5) 
22.55 (95%CI; 19.7 
to 25.8) 
0.359 0.008 
HRmax (bpm)† 137 (88 to 181) 131 (88 to 181) 139 (88 to 169) 0.32  
HRR (bpm) 71.5 (95% CI; 67.7 
to 75.4) 
65.1 (95% CI; 58.9 
to 71.3) 
75.43 (95% CI; 70.69 
to 80.17) 
0.009* 0.061 
VAT (ml·kg-1·min-1) † 13.1 (8.2 to 29.7) 13.3 (8.2 to 26.0) 16.6 (8.6 to 30.0) 0.001***  
VAT (L·min-1) † 1.3 (0.7 to 2.5) 1.15 (0.7 to 2.0) 1.35 (0.7 to 2.5) 0.027*  
HR at VAT (bpm) 94 (95% CI; 91 to 
97) 
90 (95% CI; 85 to 
94) 
97 (95%CI; 93 to 
101) 
0.016* 0.05 
VAT (% of VO2peak) 67.5 (95%CI; 65 to 
70) 
61.3 (95%CI; 58 to 
65) 
71.1 (95%CI; 68 to 
74) 
<0.001*** 0.151 
VAT (% of predicted 
VO2peak) Tr 
56.8 (95%CI; 52 to 
63) 
51.8 (95%CI; 45 to 
60) 
60.1 (95%CI; 53 to 
68) 
0.003** 0.08 
Table 3
  
VAT (% of HRR) 45.90 (95%CI; 43 
to 49) 
39.45 (95%CI; 35.6 
to 43.3) 
49.77 (95%CI; 46.5 
to 53.0) 
<0.001*** 0.129 
VAT (% of HRmax) 71.58 (95%CI; 70.1 
to 73.1) 
69.81 (95%CI; 66.9 
to 72.7) 
72.64 (95%CI; 70.9 
to 74.4) 
0.072 0.029 
 
 
CPET, cardiopulmonary exercise test. VO2Peak, Peak oxygen consumption. HRmax, maximum heart rate. Bpm, beats per 
minute. HRR, heart rate reserve.  VAT = ventilatory anaerobic threshold. HR, heart rate. *P<0.05, **P<0.01, ***P<0.001.  
†,Variables are reported as median (minimum and maximum) values analysed using a non-parametric test. Tr, 
transformed using log10 transformation and reported as arithmetic mean for meaningful interpretation. 
Table 4. Relation between predicted and measured variables stratified by mode of exercise 
 
 Pooled Cycle Treadmill P-value Partial eta-
squared 
 
Predicted 
HRmax (adjusted 
for β-blockade; 
bpm) † 
136 (118 to 174) 138 (126 to 174) 134 (118 to 167) 0.009**  
 
VAT (% of 
predicted 
HRmax adjusted 
for β-blockade) 
67.97 (65.86 to 70.07) 62.74 (59.68 to 65.80) 71.10 (68.50 to 73.71) <0.001*
* 0.131 
 
Predicted HRR 
(adjusted for β-
blockade; bpm) 
 
77.85 (95%CI; 75.04 to 
80.66) 
77.93 (95% CI; 73.19 to 
82.68) 
77.8 (95%CI; 74.24 to 
81.36) 0.965 <0.001 
 
VAT (% of 
Predicted HRR 
adjusted for β-
blockade)† 
40.35 (9.57 to 87.93) 30.49 (9.57 to 69.23) 47.06 (12 to 87.93) <0.001*
** 
 
 
       
Predicted VO2Peak 
(ml·min-1) 
2272.14 (95% CI; 
2184.11 to 2360.17) 
2258.79 (95% CI; 
2114.05 to 2403.53) 
2280.35 (95%CI; 
2166.68 to 2394.01) 0.815 <0.001 
 
VO2Peak (% of 
Predicted 
VO2Peak) 
87.85 (95%CI; 84.11 to 
91.58) 
89.99 (95%CI; 82.64 to 
97.35) 
86.56 (95% CI; 82.40 to 
90.72) 0.380 0.007 
 
HRmax, maximal heart rate. Bpm, beats per minute. VAT, ventilatory anaerobic threshold. HRR, heart rate reserve.  VO2Peak, 
Peak oxygen consumption 
*P<0.05, **P<0.01, ***P<0.001. †, Variables are reported as median (minimum and maximum) values and analysed using a 
non-parametric test. 
 
 
Table 4
 
 
 
 
 
 
Predicted HRR using current guidelines, accounting for beta-blockade. Baseline CRF category based on Taylor et al. (2016); low fit <5 METs for women, and 
<6 METs for men, mod fit 5<7METs for women, and 6<8 METs for men, high fit ≥7 METs for women, and ≥8 METs for men. VAT, ventilatory anaerobic 
threshold. HRR, heart rate reserve. MET, metabolic equivalent where 1 MET = 3.5ml·kg-1·min-1. 
Low Fit Mod Fit High Fit
Treadmill 25.9 48.6 40 61.3 51.7 78.3
Cycle 21.6 35.7 24.7 38.3 22.7 50
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Figure 1. Inter-quartile range of VAT identification based on predicted HRR (% range) in cardiac patients separated by exercise modality and CRF category  
Figure 1
Figure 2a. A case study highlighting how the 40-70% HRR prediction equation may under-estimate individualised exercise prescription. 
A 58 year-old male taking beta-blockers with a BMI of 24.8, VO2peak of 35.28 ml·kg-1·min-1 in the high fitness category. CPET was 
conducted on a treadmill. Solid line corresponds to heart rate at ventilatory anaerobic threshold, which is 125bpm. 
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Heart rate at VAT = 125bpm.
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Heart rate at VAT = 72bpm.
Figure 2b. A case study highlighting how the 40-70% HRR prediction equation may over-estimate individualised exercise 
prescription. A 71 year-old male not taking beta-blockers with a BMI of 25.8, VO2peak of 13.82 ml·kg-1·min-1 in the low fitness 
category. CPET was conducted on a cycle. Solid line corresponds to heart rate at ventilatory anaerobic threshold, which is 72bpm. 

